Referee #1:
Martin et al reported that PML negatively regulates TBX2. They suggest that this downregulation contributes to senescence because cells depleted of TBX2 senesce and overexpression of TBX2 inhibits PML-induced senescence. The role of TBX2 in senescence was already known from the work of van Lohuizen and colleagues who used murine cell models to show that Tbx2 repress several CKIs implicated in senescence. Here, Martin and colleagues extend these observations to human cells. Mechanistically, PMLIV was found as a repressor of Tbx2 and capable of binding to the Tbx2 promoter. Also, Tbx2 was found to interact with PML and prevents its binding to the endogenous Tbx2 promoter. Overall, this paper significantly advances our current knowledge on how PML regulates senescence acting as a gene repressor. The data rise several important questions that the authors should clarify: 1-How does PML bind to the Tbx2 promoter knowing that PML is not a DNA binding protein? Is this a direct or indirect effect? What is the transcription factor or DNA binding protein that directly mediates PML binding to the Tbx2 promoter? This promoter contains SP1 and MZF1 DNA binding consensus sequences and SP1 and MZF1 are known to interact with PML. These points lead the reader to wonder if the recruitment of PML to the promoter could be made via these transcription factors. Another possibility comes from recent work proposing that PML represses many E2F genes during senescence (Verniere Genes and Dev 2011) . Is Tbx2 an E2F target gene? 2-Is Tbx2 repression depending on PML bodies or is a function of PML in the nucleoplasm? 3-PML-mediated senescence requires Rb and p53. Is Rb or p53 required for PML-mediated repression of Tbx2 ?
Minor points:
In graphs of figures 3A, 3D, 1DS1A, S3B error bars should be added. In the current manuscript by Martin et al, the authors set out to identify genes that are downregulated in senescence. For this they studied three different senescent states, namely replicative senescence, RASV12-and PML-IV induced senescence. In all three cases the authors observed a decrease in TBX2 expression levels. This is an interesting finding, as overexpression of TBX2 is known to immortalize mouse fibroblasts and TBX2 is highly expressed in multiple human cancers. The authors use this observation as a basis for their further studies and focus on how PML-IV may regulate TBX2 expression. They also provide evidence for a positive feedback loop in which TBX2 in turn inhibits PML-IV. This paper covers an important topic and many of the key experiments are convincing. The authors provide a certain level of mechanistic insight into the PML-TBX2 network, but to my opinion a number of additional experiments are required to merit publication in EMBO Journal.
In essence there are two parts to this paper, the first being that PML-IV represses transcription of TBX2. Here the authors have convinced me that this a physiologically relevant phenomenon. The observation that PML induces senescence by inhibiting TBX2 is both novel and interesting. Having said that, I do feel that the authors should unravel in more detail how PML-IV represses TBX2 transcription.
The authors show that PML represses the TBX2 promoter and binds to a specific promoter region (-911 to -651). It would be an important experiment to test if this region is indeed required for repression by PML-IV. Subsequently the authors could dissect which specific promoter elements are required for the observed repression. These experiments are straightforward, but have the potential to provide considerable insight into how PML-IV represses TBX2 expression. These experiments could for example bring us to certain unexpected transcription factor binding sites, which would be very informative.
The second part of this paper concerns the positive feedback loop which is referred to in the title. The authors argue that TBX2 and PML-IV act in a positive feedback loop through direct binding. To my opinion this is the least convincing part of the paper. I would therefore be in favour of changing the title of this paper in such a manner that the emphasis lies on the first part of the paper.
Admittedly, it is very difficult to prove that this loop is of any relevance to senescence signalling, as the repression domain of TBX2 may simultaneously be important for both the loop and for effector target repression. Nevertheless the authors could perform a few experiments in support of their conclusion that TBX2 requires its repression domain to inhibit PML-IV. First, they should include the delta RD mutant in their analyses in figure 4D . If TBX2 counteracts PML-IV through its RD domain, this mutant should not cause loss of TBX2 repression.
Secondly, the authors could revisit their co-IP experiments in figure 4A , and perform the reverse IP. In the current figure, pulling on Flag-PML-IV, and blotting for TBX2 full length or the RD mutant, there is a background band that runs exactly at the hight of the RD mutant. This complicates interpretation of this figure. In a reverse IP (pulling on TBX2 and blotting for Flag-PML-IV) I expect that this problem would be solved as the Flag antibody does not give such background bands.
Minor issues: I would recommend that the authors include the relative luciferase activities (=only corrected for B Gal activity), in addition to showing it as fold repression or fold derepression. I actually find the fold derepression label confusing. These relative values would more easily allow comparison of the data in figures 2B and 4C.
The authors could run through the labels of their figures, which could be more explicit. For example in figure 1 they could say 'sh TBX2 -2' rather that 'sh 2' and in 2A the Y axis could read 'relative TBX2 expression' rather than 'relative gene expression'. Making these kinds of changes makes the figures easier to read.
Referee #3:
Martin et al. describe that PML directly represses TBX2/3 expression during senescence, and TBX2/3, in turn, block PML pro-senescence activity through physical association. Experiments are well designed and the finding is interesting. I have a few suggestions that would reinforce the authors' interpretations.
Major points 1. Due to the negative circular loop between PML and TBX2/3, it is unclear what is the actual senescence effector(s). Does PML effectively blocks TBX's downstream targets that are essential for senescence, or does TBX2/3 just block the pro-senescence downstream activity of PML? While TBX has its own pro-senescence downstream targets (eg CDKIs), the result showing that TBX2TB mutant, which doesn't bind DNA, still rescues PML-senescence (Fig. 3D) supports the latter. The authors show that knockdown of TBX2 is sufficient to induce senescence, but does sh-TBX2 enhance PML activity (other than TBX2 repression)? Also it would be interesting to know whether sh-TBX2-induced senescence is dependent on PML (does sh-PML rescue sh-TBX senescence?).
2. Also, does the TBX2TB mutant replace the PML occupancy from the TBX2 promoter? 3. The expression pattern of TBX2 during senescence ( Figure 5B ) is reminiscent of cell cycle genes.
I wonder whether TBX2/3 are cell cycle regulated genes. Are they downregulated during quiescence as well or is there any specific cell cycle pattern in TBX2 expression? Moreover, we show that inhibition of p130 function with the oncoviral protein HPV16E7 prohibits recruitment of PML-IV to the TBX2 promoter as well as PML-mediated TBX2 repression. Together, these results argue that a p130/E2F4 repressor complex is instrumental for the recruitment of PML-IV to the TBX2 promoter. In further support of this notion is our finding that PML, p130 and E2F4 coprecipitate with each other in senescent cells. These novel findings have been included in the new Figure 3 and the text has been modified accordingly in the « abstract », « results section » on pp 10-11 and « discussion » pp18-21.
2-Is Tbx2 repression depending on PML bodies or is it a function of PML in the nucleoplasm?
To address this point we used the cytomegaloviral protein IE1, which disrupts PML NBs without affecting overall levels of PML protein. We previously showed that PML-induced senescence is independent from the integrity of PML NBs. We now show that the integrity of PML NBs is equally dispensable for TBX2 repression as well as PML-IV recruitment to the TBX2 promoter. This new data have been added as Figures 2 D-E and the manuscript has been modified accordingly on pp 9-10 in the « result section « and p20 of the « discussion ».
3-PML-mediated senescence requires Rb and p53. Is Rb or p53 required for PML-mediated repression of Tbx2 ?
We show that the Rb-family member p130 but not Rb plays a major role in TBX2 repression in cells undergoing PML-induced senescence. Please, refer to point 2 above for a detailed discussion.
By contrast, we could not find any evidence for a direct involvement of p53 (data not shown).
Minor points:
In graphs of figures 3A, 3D, 1DS1A, S3B error bars should be added.
Error bars have now been added as requested.
Page 7. References of Xu et al and Kumar et al should be in the same parenthesis
This mistake has been amended.
Page 8: Space in -911and -651 bps
This mistake has been amended. Figure 3 and the text has been modified accordingly in the « abstract », « results section » on pp 10-11 and « discussion » pp18-21. figure 4D . If TBX2 counteracts PML-IV through its RD domain, this mutant should not cause loss of TBX2 repression.
As suggested by the reviewer, we have performed this experiment and the results are depicted in the new Figures 5D and S5A and S5B. We show there-in that the TBX2ΔRD1 mutant protein does not impede PML-IV binding to the TBX2 promoter, while the TBX2 wild-type and DNA-binding deficient TBX2TB mutant proteins do block it. The text in the MS has been modified accordingly on p14. figure 4A , and perform the reverse IP. In the current figure, pulling As suggested by the reviewer we have performed this type of experiment and the new data is now shown in the new Figure 5A and the text amended on p13 of the MS. We show here that the interaction between PML and TBX2ΔRD1 is greatly reduced but not completely abolished when compared to wild-type TBX2. 
Secondly, the authors could revisit their co-IP experiments in

